Allergen immunotherapy downregulate CD86 expression on dendritic cells and upregulate CTLA-4 expression on T cells in a mouse asthma model Source: Eur Respir J 2005; 26: Suppl. 49, 135s Year: 2005
High concentration of antigen induces allergic mice T cells anergy with depressing CD86 expression on antigen-presenting cells Source: Eur Respir J 2002; 20: Suppl. 38, 28s Year: 2002
Modified mRNA encoding Foxp3 protects against allergic asthma in mice by rebalancing T helper cell responses through an IL-23 / IL-17A-dependent mechanism Source: Annual Congress 2012 - Treating childhood asthma Year: 2012
The effect of Immunotherapy on the expression of costimulatory pathway molecules on dendritic cells and T cells in asthmatic mice Source: Eur Respir J 2003; 22: Suppl. 45, 483s Year: 2003
Different Th1, Th2, Th17 and Treg associated chemokine local pattern expression in lung in a murine model of allergic inflammation Source: Annual Congress 2011 - T-cell subsets Year: 2011
T-cells from allergic mice co-expressing IL-5 mRNA together with CD25 Source: Eur Respir J 2002; 20: Suppl. 38, 27s Year: 2002
Allergen specific immunotherapy induces T-cell anergy via upregulating CTLA-4 and downregulating CD86 in a murine OVA-sensitized model Source: Eur Respir J 2004; 24: Suppl. 48, 349s Year: 2004
IL-10 produced by CD4+ T cells is essential for the development of airway hyperresponsiveness via suppression of endogenous IL-12 Source: Eur Respir J 2005; 26: Suppl. 49, 24s Year: 2005
The effects of DC expressing PD-L1 on CD4+ T cell in a murine model of allergic airway disease Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007
Enhanced expression of IL-18 and increased CD8+ T cells and eosinophils in the airways of asthma death Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation Year: 2010
mRNA expression for Th2 and Th1 derived cytokines in induced sputum Source: Eur Respir J 2001; 18: Suppl. 33, 271s Year: 2001
MiR-1165-3p downregulated in Th2 cells inhibits Th2 differentiation in allergic asthma by targeting PPM1A Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease Year: 2019
Interferon-γ-pretreated dendritic cells induced dual Th1 and Th2 responses and failed to prevent development of allergic airway inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 230s Year: 2006
Upregulation of CD4+ and CD8+ cells expressing CX3CR1 in asthmatics Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma Year: 2006
Differentiation of bronchial epithelial cells in the presence of Th2 cytokines increases the expression of the human cathelicidin hCAP18/LL-37 Source: Annual Congress 2009 - Airway cell biology Year: 2009
IL-15 transpresentation in circulating progenitors of NK cells controls their differentiation potential, STAT6 activation and IL-13 production Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response Year: 2005
Fevipiprant is superior to montelukast in suppressing type 2 cytokine production from mast cell stimulated human Th2 cells Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases Year: 2019
ILC2 cells from severe allergic and eosinophilic asthma demonstrate increased expression of TSLP receptor (TSLPR) and enhanced proliferative capacity. Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021
Macrophages induce an allergen-specific and long-term suppression in a mouse asthma model Source: Eur Respir J 2005; 26: 1040-1046 Year: 2005
Dendritic cells (DC) and expression of Th1 and Th2-attractant chemokines in the airways of asthmatics and controls Source: Annual Congress 2009 - Inflammatory cells and cytokines Year: 2009